A Guidebook for Medical and Professional Schools, Second Edition.
This book represents a significant step to engage health professions schools in addressing global health challenges
Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Countdown to zero
2011- 2015
Les enfants sont notre avenir. Des politiques et plans bien conçus permettent aux gouvernements de promouvoir la santé mentale des enfants dans l'intérêt des familles, de la communauté et de la société tout entière.
Les enfants et les adolescents qui sont en bonne santé mentale peuvent se ...procurer et maintenir un bien-être et un comportement social et psychologique optimums. Ils ont le sens de l’identité et de la confiance en soi, de la famille stable et des rapports d’égalité, la capacité d’être productif et d’apprendre, le potentiel pour relever les défis du développement et se servir des ressources culturelles pour porter la croissance à un niveau aussi élevé que possible.
more
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses
Attention-Deficit/Hyperactivity Disorder
Epilepsia, 55(4):475–482, 2014
doi: 10.1111/epi.12550
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...ions caused by AMR organisms. With drugs not listed on the essential drugs list (EDL), problems of increased morbidity, costs of extended hospitalisation and mortality are extremely serious. The problem of susceptibility to and spread of infections caused by multidrug-resistant (MDR) infectious agents is fuelled by factors such as limited access to clean water and sanitation to ensure personal hygiene, malnutrition, and the HIV/TB epidemic.
more
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...opulation has lost ground since the 1990s in virtually all important health indicators, leaving South Africa with a high burden of infectious disease.
August 2011, Vol. 101, No. 8 SAMJ
more
The Onchocerciasis Control Programme in West Africa (OCP) undertook regional and large scale frght against onchocerciasis in West Africa in 1974 using a vector control strategy. By 2002 OCP had succeeded in eliminating the disease as a public health, socio-economic and development problem in 10 out ...of I I countries. This campaign was highly technical and expensive. ln 1987, Merck & Co.,lnc. committed themselves to provide ivermectin free of charge for as long as needed to onchocerciasis endemic countries. This made it possible to envrsage the extension of onchocerciasis control activities to the remaining endemic countries in Africa.
more
Ce rapport présente les principaux résultats de l’OMS atteints en 2022 au Niger en étroite collaboration avec le Gouvernement du Niger, les partenaires et d’autres acteurs, dans le cadre de la mise en œuvre du 13e PGT, et dont quatre piliers ont guidé les interventions de l’OMS, à savoir... l’instauration de la couverture sanitaire universelle, l’intervention dans les situations d’urgence sanitaire, la promotion de la santé et du bien-être des populations et le soutien au pays.
more
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...velopment of next-generation vaccines against COVID-19 variants and we are planning studies to answer critical scientific questions related to the durability of immunity, effectiveness of mixed-vaccine regimens, and vaccine effectiveness in vulnerable populations such as pregnant women. We are also bringing forward our plans to develop vaccines that could protect against multiple COVID-19 variants and other coronavirus specie
more